Seagen Inc.：Pfizer + Seagen

Pfizer + Seagen

Seagen,aworld-leaderinantibody-drugconjugates(ADCs),wewillbeattheforefrontofcancercare.Together,wewillbringnewhopetopatientseverywhere.。其他文章還包含有：「2023年截至目前最大型收購案登場！輝瑞（Pfizer）斥資430...」、「OurHistory–Seagen」、「PfizerCompletesAcquisitionofSeagen」、「Seagen」、「Seagen」、「SeagenInc.」、「SGEN-SeagenInc(西雅圖遺傳)」、「輝瑞以430億美元收購Seagen加強癌症藥物開發」

查看更多離開網站

Seagen stock

Provide From Google

2023 年截至目前最大型收購案登場！輝瑞（Pfizer）斥資430 ...

https://geneonline.news

Seagen 為來自美國華盛頓州的生技公司，創立於1998 年，專注於抗體藥物複合體（Antibody-Drug Conjugates, ADC）的癌症藥物開發，並自稱為ADC 技術的先驅 ...

Provide From Google

Our History – Seagen

https://www.seagen.com

Seattle Genetics, Inc. changes its name to Seagen Inc. to reflect the transformation of the company from its Seattle roots into a global operation. 2021.

Provide From Google

Pfizer Completes Acquisition of Seagen

https://www.pfizer.com

Seagen is a world-leader in ADC technology, a transformative modality that is emerging as a powerful tool across a broad range of cancers ...

Provide From Google

Seagen

https://en.wikipedia.org

Seagen Inc. (formerly Seattle Genetics, Inc.) is an American biotechnology company focused on developing and commercializing innovative, empowered monoclonal ...

Provide From Google